P PRIMESTOCKFINDER.COM

BPM Shares BPM Minerals Limited

ASX · ASX
$0.19 +2.78% Prices as of close 2026-10-27

Last in our picks 2026-09-30 — not in the current list; analysis below is from that screen

Included only if biotech exposure via health-tech assets; otherwise liquidity and fit are weaker.

  • ▸Fit to biotech category is weaker and conviction is limited.
  • ▸Above 50-day MA (+8.14%)
  • ▸Above 200-day MA — long-term uptrend

Trend: BPM is trading below the 50-day average (-7.50%), RSI 59 — neutral momentum, with a 3-month return of +12.12%.

Valuation & quality: BPM Minerals Limited trades on price-to-book 2.98; fundamentals show net margin 0.0%, return on equity -68.3%, revenue growth 213.0% year on year.

Our screen: BUY (score 2) — Included only if biotech exposure via health-tech assets; otherwise liquidity and fit are weaker.

Computed from end-of-day data; not personal advice.

0.34 0.14 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.14 – 0.34.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-29.00%+4.50%-13.00%-30.00%+14.30%+6.30%+23.50%-9.50%
Market cap
$25.3M
EPS (ttm)
$-0.04
Price / book
2.98
Beta
1.33
Net margin
0.0%
ROE
-68.3%
Revenue growth
213.0%
Revenue (ttm)
$99,108
Free cash flow
$-1,473,477
Debt / equity
0%
52-wk range
$0.12 – $0.39
Volume
59,857
Avg volume (3m)
401,564
RSI (14)
58.7
vs 50-day MA
-7.50%
1-mo return
-9.76%
3-mo return
+12.12%
Volume z-score
0.09

BPM Minerals Limited engages in the exploration and development of mineral projects in Australia. The company explores for gold, and nickel minerals. BPM Minerals Limited was incorporated in 2020 and is based in West Perth, Australia.

Sector: Basic Materials · Industry: Other Precious Metals & Mining · Australia · Website

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.